Overview
Hepatitis is inflammation of the liver, which can result from viral infection, alcohol, drugs and toxins, metabolic disease, or autoimmune processes. The most common infectious causes are the hepatitis viruses, notably hepatitis A, B, and C, which differ in their routes of transmission, natural history, and potential to become chronic. Acute hepatitis may resolve or, particularly with hepatitis B and C, progress to chronic infection that drives ongoing liver injury, fibrosis, cirrhosis, liver failure, and hepatocellular carcinoma. Manifestations range from asymptomatic infection to jaundice, fatigue, and abdominal symptoms, and assessment relies on clinical evaluation, liver-function tests, serology, viral markers, imaging, and measures of liver stiffness. Management depends on the cause and includes antiviral therapy for chronic viral hepatitis, supportive and lifestyle measures, and surveillance for complications, while vaccination prevents certain forms. Research relevant to this topic includes retrospective hospital-based studies of chronic liver disease, the treatment of chronic hepatitis B with antiviral agents such as tenofovir, the role of angiogenic markers in hepatocellular carcinoma complicating hepatitis C infection, the assessment of liver stiffness in cirrhosis, the relationship between nutrition, epigenetics, and liver disease, and the evaluation of co-infections and comorbidities, reflecting the spectrum of inflammatory liver disease and its consequences.
Research published in this journal
11 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Treatment of Chronic Hepatitis B With Tenofovir At The University Teaching Hospital Campus of Lome (Togo)
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Epigenetics and Nutrition
Syphilis and Beyond: A Comprehensive Analysis of Associated Infections and Comorbidities in a Five-Year Retrospective Study in the United Arab Emirates (2018-2022)
Liver Stiffness by ARFI does not Correlate with Decompensation and Portal Hypertension in Patients with Cirrhosis
Pseudotumor Tuberculosis Of Liver: A Rare Entity
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
How this research is being cited
The 11 articles above have been cited 19 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BioMed Research International
-
2025 · BMC Gastroenterology
-
2025 · BMC Gastroenterology
-
2024 · Risk Management and Healthcare Policy
-
2024 · Risk Management and Healthcare Policy
-
2024 · Research Square (Research Square)
-
2023 · Journal of Spleen and Liver Research
-
2023 · Journal of Spleen and Liver Research
A sample of recent works citing this journal's research on Liver Hepatitis, linking to each citing work.